Having trouble accessing articles? Reset your cache.

Santhera, Ipsen in fipamezole deal

Santhera Pharmaceuticals Holding AG (SIX:SANN) granted Ipsen Group (Euronext:IPN) exclusive rights outside the U.S.,

Read the full 140 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE